Daniel Lachapelle, president of Foster Wheeler Biokinetics, said, “Foster Wheeler Biokinetic’s intends to offer its clients the most innovative solutions on the market, as part of our strategy to partner with clients and suppliers to continuously identify and conquer today’s unique set of challenges. Dramatically reducing speed to market is key among those challenges. Foster Wheeler Biokinetics’, combined with G-Con’s innovative approach to significantly reducing our clients’ time to market combines very nicely with our global reach in the world of pharmaceuticals and biotechnology and allows us to offer our existing clients one more approach to flexible, scalable facilities.”
Barry Holtz, president of G-Con Manufacturing, said, “Foster Wheeler has an impressive portfolio of successful global pharmaceutical and biotechnology projects and they are committed to being the leading engineering firm in this segment of the industry. We have a common goal – to use our complementary skill sets to offer the market a solution that gets our mutual clients to market in a comprehensive, self-contained, faster and flexible way.